Thus, the established point of view on the beneficial effects of adiponectin is based on the following data: Decrease of this parameter in patients with coronary artery disease [25]; decreased expression of adiponectin gene in epicardial adipose tissue in patients with cardiovascular disease [8]; inverse correlation of adiponectin levels and atherogenic blood plasma index [26]. Here, ADIPOQ is linked to coronary artery disorder.